ANKH | ANKH inorganic pyrophosphate transport regulator | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images/68104/1339_E4_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
CLCN4 | Chloride channel, voltage-sensitive 4 | Predicted membrane proteins Transporters
| ![](/images/31313/ihc_selected_60x60.jpg) | ![](/images/63637/1210_D7_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31313/69135_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/43019/102123_B_5_8_rna_selected_60x60.jpg) | Expressed in all |
CTNS | Cystinosin, lysosomal cystine transporter | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images/46947/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
EI24 | Etoposide induced 2.4 | Cancer-related genes Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/47165/ihc_selected_60x60.jpg) | | ![](/images/47165/ihc_cell_selected_60x60.jpg) | ![](/images/47165/107102_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
FLVCR1 | Feline leukemia virus subgroup C cellular receptor 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/46646/ihc_selected_60x60.jpg) | ![](/images/46646/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/46646/106727_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
FLVCR2 | Feline leukemia virus subgroup C cellular receptor family, member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/37984/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37984/80131_B_9_1_rna_selected_60x60.jpg) | Mixed |
HIATL1 | Hippocampus abundant transcript-like 1 | Predicted membrane proteins Transporters
| ![](/images/17978/ihc_selected_60x60.jpg) | ![](/images/17978/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17978/41361_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/8338/ihc_cell_selected_60x60.jpg) | ![](/images/8338/23048_A_6_1_rna_selected_60x60.jpg) | Expressed in all |
LAPTM4B | Lysosomal protein transmembrane 4 beta | Predicted membrane proteins Transporters
| ![](/images/20782/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20782/46733_B_8_8_rna_selected_60x60.jpg) | Expressed in all |
LAPTM5 | Lysosomal protein transmembrane 5 | Predicted membrane proteins Transporters
| ![](/images/51293/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51293/116975_B_9_8_rna_selected_60x60.jpg) | Expressed in all |
LETM1 | Leucine zipper-EF-hand containing transmembrane protein 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | ![](/images/11029/ihc_cell_selected_60x60.jpg) | ![](/images/11029/27587_A_6_3_rna_selected_60x60.jpg) | Expressed in all |
MFSD2A | Major facilitator superfamily domain containing 2A | Predicted membrane proteins Transporters
| ![](/images/43107/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43107/93229_B_7_7_rna_selected_60x60.jpg) | Mixed |
MFSD6L | Major facilitator superfamily domain containing 6-like | Predicted membrane proteins Transporters
| ![](/images/23164/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23164/51217_B_1_7_rna_selected_60x60.jpg) | Tissue enriched |
MFSD8 | Major facilitator superfamily domain containing 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/44802/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/44802/100556_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/67533/150383_B_8_2_rna_selected_60x60.jpg) | Group enriched |
MPC1 | Mitochondrial pyruvate carrier 1 | Disease related genes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/45119/100235_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MPC2 | Mitochondrial pyruvate carrier 2 | Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/56091/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/56091/131175_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MTCH1 | Mitochondrial carrier 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| ![](/images/15971/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15971/36385_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
MTCH2 | Mitochondrial carrier 2 | Mitochondrial proteins Predicted membrane proteins Transporters
| ![](/images/38390/ihc_selected_60x60.jpg) | | ![](/images/38390/ihc_cell_selected_60x60.jpg) | ![](/images/38390/78376_B_9_6_rna_selected_60x60.jpg) | Expressed in all |
NIPA1 | Non imprinted in Prader-Willi/Angelman syndrome 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/23269/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23269/55280_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
NIPA2 | Non imprinted in Prader-Willi/Angelman syndrome 2 | Predicted membrane proteins Transporters
| ![](/images/67160/153978_A_8_7_selected_60x60.jpg) | ![](/images/71342/1440_D5_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/67160/153977_A_2_2_rna_selected_60x60.jpg) | Expressed in all |
NIPAL3 | NIPA-like domain containing 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/39978/ihc_selected_60x60.jpg) | ![](/images/39978/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39978/85116_A_1_5_rna_selected_60x60.jpg) | Expressed in all |
NIPAL4 | NIPA-like domain containing 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/38259/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/38259/80182_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
NPC1 | Niemann-Pick disease, type C1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/26618/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/26618/ihc_cell_selected_60x60.jpg) | ![](/images/26618/55248_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
NPC2 | Niemann-Pick disease, type C2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins Transporters
| ![](/images/835/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/835/1744_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
OCA2 | Oculocutaneous albinism II | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/36403/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36403/79997_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
OXA1L | Oxidase (cytochrome c) assembly 1-like | Mitochondrial proteins Predicted membrane proteins Transporters
| ![](/images/3531/ihc_selected_60x60.jpg) | | | ![](/images/3531/11445_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
PQLC2 | PQ loop repeat containing 2 | Predicted membrane proteins Transporters
| ![](/images/57810/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/57810/130625_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
RFT1 | RFT1 homolog (S. cerevisiae) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images/60327/1252_E11_4_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
SFXN4 | Sideroflexin 4 | Disease related genes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | ![](/images/20872/ihc_cell_selected_60x60.jpg) | ![](/images/18028/41567_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
SLC10A1 | Solute carrier family 10 (sodium/bile acid cotransporter), member 1 | Predicted membrane proteins Transporters
| ![](/images/42727/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42727/95205_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/4795/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4795/13413_B_9_2_rna_selected_60x60.jpg) | Group enriched |
SLC10A3 | Solute carrier family 10, member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images/21656/ihc_selected_60x60.jpg) | ![](/images/21656/if_selected_60x60.jpg) | ![](/images/21656/ihc_cell_selected_60x60.jpg) | ![](/images/21656/49075_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
SLC10A4 | Solute carrier family 10, member 4 | Predicted membrane proteins Transporters
| ![](/images/28835/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28835/61588_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
SLC10A5 | Solute carrier family 10, member 5 | Predicted membrane proteins Transporters
| ![](/images/25966/ihc_selected_60x60.jpg) | ![](/images/25966/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/25966/55786_A_2_1_rna_selected_60x60.jpg) | Mixed |
SLC10A7 | Solute carrier family 10, member 7 | Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/39996/ihc_selected_60x60.jpg) | ![](/images/57906/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39996/85747_B_9_2_rna_selected_60x60.jpg) | Mixed |
SLC11A1 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 | Predicted membrane proteins Transporters
| ![](/images/29590/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29590/96871_A_2_8_rna_selected_60x60.jpg) | Tissue enhanced |
SLC11A2 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/32139/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/32139/89110_A_3_2_rna_selected_60x60.jpg) | Expressed in all |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images/18107/if_selected_60x60.jpg) | ![](/images/14967/ihc_cell_selected_60x60.jpg) | ![](/images/14967/33483_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC12A2 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 2 | FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/20130/47733_A_3_3_selected_60x60.jpg) | ![](/images/63697/1132_A7_3_selected_60x60.jpg) | ![](/images/20130/ihc_cell_selected_60x60.jpg) | ![](/images/20130/47732_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28748/141823_A_3_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC12A4 | Solute carrier family 12 (potassium/chloride transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/41138/ihc_selected_60x60.jpg) | ![](/images/41138/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41138/86919_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/72058/159045_A_2_1_rna_selected_60x60.jpg) | Tissue enriched |
SLC12A6 | Solute carrier family 12 (potassium/chloride transporter), member 6 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/34563/ihc_selected_60x60.jpg) | ![](/images/34563/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/34563/70208_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
SLC12A7 | Solute carrier family 12 (potassium/chloride transporter), member 7 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/41652/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41652/87092_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
SLC12A8 | Solute carrier family 12, member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/31123/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/31123/64858_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
SLC13A1 | Solute carrier family 13 (sodium/sulfate symporter), member 1 | Predicted membrane proteins Transporters
| ![](/images/62714/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62714/143258_B_7_5_rna_selected_60x60.jpg) | Tissue enhanced |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14963/141351_B_8_3_rna_selected_60x60.jpg) | Group enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14736/33478_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |